Automated High-Density Bioreactor Boosts CHO Cell Titers

A recent study published in Biotechnology Progress (2024) describes an automated high inoculation density fed-batch bioreactor that leverages N-1 perfusion to double titers while accommodating clonal diversity. The system streamlines cell culture processes, enhancing productivity for biopharmaceutical manufacturing.

Key highlights:

• Automation: The bioreactor integrates N-1 perfusion to maintain high cell densities before inoculation.
• Productivity: Titers were doubled compared to conventional fed-batch processes.
• Flexibility: The method supports a range of CHO cell clones, improving manufacturing versatility.

For detailed protocols and data, consult the original paper: PubMed ID 38013663.